Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Brain Neoplasms 7Breast Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 2Oligodendroglioma 2Neoplasms 2Lung Neoplasms 2Head and Neck Neoplasms 2Glioma 2Glioblastoma 2Ependymoma 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Astrocytoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Ewing 1Rectal Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Myelodysplastic Syndromes 1Melanoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

Fluorouracil 12Radiotherapy 8Cisplatin 8pembrolizumab 4Papillomavirus Vaccines 4Mitomycin 4Irinotecan 4Cyclophosphamide 4Cetuximab 4Light Coagulation 3Interleukin-12 Subunit p35 3Capecitabine 3fludarabine phosphate 2fludarabine 2atezolizumab 2aldesleukin 2Watchful Waiting 2Vaccines 2Trastuzumab 2Surveys and Questionnaires 2Radiation 2Quality of Life 2Paclitaxel 2Oxaliplatin 2Erlotinib Hydrochloride 2Early Intervention, Educational 2Carboplatin 2Biopsy 2toripalimab 1tipifarnib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Anus Neoplasms × alovudine × Clear all
NCT01717391 2019-03-26

[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers

University of Iowa

Phase 2 Completed
36 enrolled 5 charts
GastrointestinalGenitourinaryGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡